136 related articles for article (PubMed ID: 25649870)
1. Timely Degradation of Wip1 Phosphatase by APC/C Activator Protein Cdh1 is Necessary for Normal Mitotic Progression.
Jeong HC; Gil NY; Lee HS; Cho SJ; Kim K; Chun KH; Cho H; Cha HJ
J Cell Biochem; 2015 Aug; 116(8):1602-12. PubMed ID: 25649870
[TBL] [Abstract][Full Text] [Related]
2. Wip1 controls the translocation of the chromosomal passenger complex to the central spindle for faithful mitotic exit.
Zhang X; Park JE; Kim EH; Hong J; Hwang KT; Kim YA; Jang CY
Cell Mol Life Sci; 2021 Mar; 78(6):2821-2838. PubMed ID: 33067654
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of Wip1 phosphatase modulates the cellular threshold of DNA damage signaling in mitosis.
Macurek L; Benada J; Müllers E; Halim VA; Krejčíková K; Burdová K; Pecháčková S; Hodný Z; Lindqvist A; Medema RH; Bartek J
Cell Cycle; 2013 Jan; 12(2):251-62. PubMed ID: 23255129
[TBL] [Abstract][Full Text] [Related]
4. APC/C(Cdh1)-dependent degradation of Cdc20 requires a phosphorylation on CRY-box by Polo-like kinase-1 during somatic cell cycle.
Hyun SY; Sarantuya B; Lee HJ; Jang YJ
Biochem Biophys Res Commun; 2013 Jun; 436(1):12-8. PubMed ID: 23643811
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of wild-type p53-induced phosphatase 1 (Wip1) plays a critical role in regulating several p53-dependent functions in premature senescent tumor cells.
Crescenzi E; Raia Z; Pacifico F; Mellone S; Moscato F; Palumbo G; Leonardi A
J Biol Chem; 2013 Jun; 288(23):16212-16224. PubMed ID: 23612976
[TBL] [Abstract][Full Text] [Related]
6. The estrogen receptor alpha pathway induces oncogenic Wip1 phosphatase gene expression.
Han HS; Yu E; Song JY; Park JY; Jang SJ; Choi J
Mol Cancer Res; 2009 May; 7(5):713-23. PubMed ID: 19435816
[TBL] [Abstract][Full Text] [Related]
7. Regulation of the antioncogenic Chk2 kinase by the oncogenic Wip1 phosphatase.
Fujimoto H; Onishi N; Kato N; Takekawa M; Xu XZ; Kosugi A; Kondo T; Imamura M; Oishi I; Yoda A; Minami Y
Cell Death Differ; 2006 Jul; 13(7):1170-80. PubMed ID: 16311512
[TBL] [Abstract][Full Text] [Related]
8. The Wip1 phosphatase PPM1D dephosphorylates SQ/TQ motifs in checkpoint substrates phosphorylated by PI3K-like kinases.
Yamaguchi H; Durell SR; Chatterjee DK; Anderson CW; Appella E
Biochemistry; 2007 Nov; 46(44):12594-603. PubMed ID: 17939684
[TBL] [Abstract][Full Text] [Related]
9. Increased wild-type p53-induced phosphatase 1 (Wip1 or PPM1D) expression correlated with downregulation of checkpoint kinase 2 in human gastric carcinoma.
Fuku T; Semba S; Yutori H; Yokozaki H
Pathol Int; 2007 Sep; 57(9):566-71. PubMed ID: 17685927
[TBL] [Abstract][Full Text] [Related]
10. p53-Independent expression of wild-type p53-induced phosphatase 1 (Wip1) in methylmethane sulfonate-treated cancer cell lines and human tumors.
Park JY; Song JY; Kim HM; Han HS; Seol HS; Jang SJ; Choi J
Int J Biochem Cell Biol; 2012 Jun; 44(6):896-904. PubMed ID: 22405851
[TBL] [Abstract][Full Text] [Related]
11. Intrinsic kinase activity and SQ/TQ domain of Chk2 kinase as well as N-terminal domain of Wip1 phosphatase are required for regulation of Chk2 by Wip1.
Yoda A; Xu XZ; Onishi N; Toyoshima K; Fujimoto H; Kato N; Oishi I; Kondo T; Minami Y
J Biol Chem; 2006 Aug; 281(34):24847-62. PubMed ID: 16798742
[TBL] [Abstract][Full Text] [Related]
12. Off-target response of a Wip1 chemical inhibitor in skin keratinocytes.
Lee JS; Park JR; Kwon OS; Kim H; Fornace AJ; Cha HJ
J Dermatol Sci; 2014 Feb; 73(2):125-34. PubMed ID: 24126074
[TBL] [Abstract][Full Text] [Related]
13. Gain-of-function mutations of PPM1D/Wip1 impair the p53-dependent G1 checkpoint.
Kleiblova P; Shaltiel IA; Benada J; Ševčík J; Pecháčková S; Pohlreich P; Voest EE; Dundr P; Bartek J; Kleibl Z; Medema RH; Macurek L
J Cell Biol; 2013 May; 201(4):511-21. PubMed ID: 23649806
[TBL] [Abstract][Full Text] [Related]
14. WIP1 phosphatase at the crossroads of cancer and aging.
Le Guezennec X; Bulavin DV
Trends Biochem Sci; 2010 Feb; 35(2):109-14. PubMed ID: 19879149
[TBL] [Abstract][Full Text] [Related]
15. Wip1 contributes to cell homeostasis maintained by the steady-state level of Wtp53.
Park HK; Panneerselvam J; Dudimah FD; Dong G; Sebastian S; Zhang J; Fei P
Cell Cycle; 2011 Aug; 10(15):2574-82. PubMed ID: 21734451
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of the wip1 gene abrogates the p38 MAPK/p53/Wip1 pathway and silences p16 expression in human breast cancers.
Yu E; Ahn YS; Jang SJ; Kim MJ; Yoon HS; Gong G; Choi J
Breast Cancer Res Treat; 2007 Mar; 101(3):269-78. PubMed ID: 16897432
[TBL] [Abstract][Full Text] [Related]
17. Regulation of the Wip1 phosphatase and its effects on the stress response.
Lowe J; Cha H; Lee MO; Mazur SJ; Appella E; Fornace AJ
Front Biosci (Landmark Ed); 2012 Jan; 17(4):1480-98. PubMed ID: 22201816
[TBL] [Abstract][Full Text] [Related]
18. The Wip1 Phosphatase acts as a gatekeeper in the p53-Mdm2 autoregulatory loop.
Lu X; Ma O; Nguyen TA; Jones SN; Oren M; Donehower LA
Cancer Cell; 2007 Oct; 12(4):342-54. PubMed ID: 17936559
[TBL] [Abstract][Full Text] [Related]
19. Wip1-expressing feeder cells retain pluripotency of co-cultured mouse embryonic stem cells under leukemia inhibitory factor-deprivated condition.
Kim JJ; Lee JS; Moon BH; Lee MO; Song SH; Li H; Fornace AJ; Cha HJ
Arch Pharm Res; 2010 Aug; 33(8):1253-60. PubMed ID: 20803129
[TBL] [Abstract][Full Text] [Related]
20. The modulation of the oxidative stress response in chondrocytes by Wip1 and its effect on senescence and dedifferentiation during in vitro expansion.
Cha BH; Lee JS; Kim SW; Cha HJ; Lee SH
Biomaterials; 2013 Mar; 34(9):2380-8. PubMed ID: 23306038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
